<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04270513</url>
  </required_header>
  <id_info>
    <org_study_id>FIT</org_study_id>
    <nct_id>NCT04270513</nct_id>
  </id_info>
  <brief_title>Flying Intervention Team for Endovascular Treatment of Acute Ischemic Stroke in Rural Areas</brief_title>
  <acronym>FIT</acronym>
  <official_title>Flying Intervention Team for Endovascular Treatment of Acute Ischemic Stroke in Rural Areas</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Munich Municipal Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Technische Universität München</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Regensburg</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Munich Municipal Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to compare time delay and safety parameters of stroke patients
      initially admitted to a rural primary stroke center (PSC) who receive endovascular treatment
      (EVT) by a Flying Intervention Team with patients who receive EVT after secondary transfer to
      a comprehensive stroke center (CSC).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A novel health care concept was implemented in the telemedical stroke network TEMPiS
      (Telemedical Project for integrative Stroke Care) to reduce time delays to EVT in stroke
      patients with large vessel occlusion: After telemedicine-assisted identification of EVT
      candidates in a PSC, a Flying Intervention Team (neuroradiologist and angiography assistant)
      is flown from a CSC via helicopter to the PSC to perform EVT in the local angiography suite.
      Flying Intervention Team service runs from 8 a.m. to 10 p.m. Patients remain at local stroke
      unit for further treatment.

      Analysis will include time delay to EVT, recanalization, symptomatic intracerebral
      hemorrhage, periprocedural complications, in-hospital complications, and mortality.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">February 1, 2018</start_date>
  <completion_date type="Anticipated">April 2020</completion_date>
  <primary_completion_date type="Actual">October 24, 2019</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>3 Months</target_duration>
  <primary_outcome>
    <measure>Time from decision for endovascular treatment to groin puncture</measure>
    <time_frame>day 1</time_frame>
    <description>Time from telemedicine-assisted decision for endovascular treatment to initiation of endovascular treatment by groin puncture</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time from symptom onset to recanalization</measure>
    <time_frame>day 1</time_frame>
    <description>Time from symptom onset to recanalization of previously occluded target artery by endovascular treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Other procedural times of hyperacute care</measure>
    <time_frame>day 1</time_frame>
    <description>Other procedural times between symptom onset, admission to PSC, first imaging, decision for endovascular treatment, initiation of endovascular treatment and completion of endovascular treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Recanalization</measure>
    <time_frame>day 1</time_frame>
    <description>Proportion of patients with antegrade reperfusion of more than half of the previously occluded target artery ischemic territory after endovascular treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Symptomatic intracerebral hemorrhage</measure>
    <time_frame>7 days</time_frame>
    <description>Proportion of patients with symptomatic intracerebral hemorrhage</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>In-hospital death or palliative care</measure>
    <time_frame>7 days</time_frame>
    <description>In-hospital death or decision for palliative care</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Periprocedural complications</measure>
    <time_frame>day 1</time_frame>
    <description>Proportion of patients with periprocedural, endovascular treatment associated complications</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>In-hospital complications</measure>
    <time_frame>7 days</time_frame>
    <description>Proportion of patients with other in-hospital complications</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">477</enrollment>
  <condition>Brain Infarction</condition>
  <arm_group>
    <arm_group_label>EVT by Flying Intervention Team in primary stroke center</arm_group_label>
    <description>Patients with ischemic stroke and large vessel occlusion admitted to a primary stroke center, for whom a Flying Intervention Team is flown to the primary stroke center in order to perform endovascular treatment.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>EVT after secondary transfer to comprehensive stroke center</arm_group_label>
    <description>Patients with ischemic stroke and large vessel occlusion admitted to a primary stroke center, who are transferred to a comprehensive stroke center for endovascular treatment.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Endovascular treatment by Flying Intervention Team</intervention_name>
    <description>After telemedicine-assisted decision for endovascular treatment, the Flying Intervention Team is transferred via helicopter to the primary stroke center and performs endovascular treatment in the local angiography suite.</description>
    <arm_group_label>EVT by Flying Intervention Team in primary stroke center</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Acute stroke patients eligible for endovascular treatment initially admitted to
        participating primary stroke center
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  Admission to participating primary stroke center (PSC) with acute symptoms of stroke

          -  Telemedicine-supported decision for endovascular treatment (EVT)

        Inclusion criteria for primary study population:

          -  Occlusion of M1, proximal M2, intracranial internal carotid artery (ICA) or basilar
             artery

          -  Decision for EVT between 8 a.m. an 10 p.m.

          -  Time from symptom onset to EVT decision within treatment window (0-6 h for M1, M2 and
             ICA occlusions, 0-24 h for basilar artery occlusions, 0-24 for M1, M2 and ICA
             occlusions with suitable mismatch in perfusion imaging performed in PSC)

          -  Endovascular treatment in PSC by Flying Intervention Team or in comprehensive stroke
             center after secondary transfer

        Exclusion criteria for primary study population:

          -  Age &gt; 85 years

          -  Alberta Stroke Program Early CT score (ASPECTS) &lt; 6

          -  Premorbid severe or moderately severe disability (modified Rankin Scale &gt; 3)

          -  Premorbid serious or advanced illness with high mortality
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gordian J Hubert, Dr. med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>München Klinik gGmbH</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>TEMPiS TeleStroke Network, Department of Neurology, Munich Municipal Hospital</name>
      <address>
        <city>Munich</city>
        <state>Bavaria</state>
        <zip>81545</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <link>
    <url>http://www.tempis.de/</url>
    <description>TEMPIS</description>
  </link>
  <reference>
    <citation>Saver JL, Goyal M, van der Lugt A, Menon BK, Majoie CB, Dippel DW, Campbell BC, Nogueira RG, Demchuk AM, Tomasello A, Cardona P, Devlin TG, Frei DF, du Mesnil de Rochemont R, Berkhemer OA, Jovin TG, Siddiqui AH, van Zwam WH, Davis SM, Castaño C, Sapkota BL, Fransen PS, Molina C, van Oostenbrugge RJ, Chamorro Á, Lingsma H, Silver FL, Donnan GA, Shuaib A, Brown S, Stouch B, Mitchell PJ, Davalos A, Roos YB, Hill MD; HERMES Collaborators. Time to Treatment With Endovascular Thrombectomy and Outcomes From Ischemic Stroke: A Meta-analysis. JAMA. 2016 Sep 27;316(12):1279-88. doi: 10.1001/jama.2016.13647.</citation>
    <PMID>27673305</PMID>
  </reference>
  <reference>
    <citation>Jahan R, Saver JL, Schwamm LH, Fonarow GC, Liang L, Matsouaka RA, Xian Y, Holmes DN, Peterson ED, Yavagal D, Smith EE. Association Between Time to Treatment With Endovascular Reperfusion Therapy and Outcomes in Patients With Acute Ischemic Stroke Treated in Clinical Practice. JAMA. 2019 Jul 16;322(3):252-263. doi: 10.1001/jama.2019.8286.</citation>
    <PMID>31310296</PMID>
  </reference>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>April 13, 2018</study_first_submitted>
  <study_first_submitted_qc>February 12, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 17, 2020</study_first_posted>
  <last_update_submitted>February 12, 2020</last_update_submitted>
  <last_update_submitted_qc>February 12, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>endovascular treatment</keyword>
  <keyword>stroke</keyword>
  <keyword>large vessel occlusion</keyword>
  <keyword>telemedicine</keyword>
  <keyword>helicopter</keyword>
  <keyword>thrombectomy</keyword>
  <keyword>mobile interventionalist</keyword>
  <keyword>flying intervention team</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brain Infarction</mesh_term>
    <mesh_term>Infarction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

